# Napoleon Trial: Optimal Treatment for Recurrent Haemorrhoidal Disease

> **NCT04101773** · NA · UNKNOWN · sponsor: **Maastricht University Medical Center** · enrollment: 558 (estimated)

## Conditions studied

- Hemorrhoids

## Interventions

- **PROCEDURE:** RBL versus sutured mucopexy versus haemorrhoidectomy.

## Key facts

- **NCT ID:** NCT04101773
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-01
- **Primary completion:** 2023-03-01
- **Final completion:** 2023-03-01
- **Target enrollment:** 558 (ESTIMATED)
- **Last updated:** 2019-09-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04101773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04101773, "Napoleon Trial: Optimal Treatment for Recurrent Haemorrhoidal Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04101773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*